Pyrrolo[1, 4]benzodiazepine Antibiotics. Biosynthetic Conversion of Tyrosine to the C2- and C3-Proline Moieties of Anthramycin, Tomaymycin, and Sibiromycin

Laurence H. Hurley, William L. Lasswell, John M. Ostrander, Ronald Parry

Research output: Contribution to journalArticle

16 Scopus citations

Abstract

This paper describes biosynthetic labeling experiments on the conversion of tyrosine to the C2- and C3-proline units of anthramycin, tomaymycin, and sibiromycin. The biosynthetic fate of all of the aromatic and side-chain hydrogens has been determined in each antibiotic by using dual tagged (3H/4C) and 2H-labeled tyrosine molecules. In addition, experiments using [15N]tyrosine and the tritiated d and l isomers of tyrosine have shed some light on the biochemical reactions which take place at the a position of tyrosine. On the basis of results of all these experiments, a biosynthetic scheme has been proposed to rationalize the apparent inconsistencies which occur between the results for the three antibiotics. This scheme proposes that a common main pathway involving proximal extradiol cleavage of Dopa and condensation to form the pyrrolo ring leads ultimately to a C-7 branch point compound. Parallel pathways from this central branch point compound lead by well-known biochemical transformations to the C2- and C3-proline units of anthramycin, tomaymycin, and sibiromycin. The reactions in these parallel pathways are suggested to be “cosmetic or after events”.

Original languageEnglish (US)
Pages (from-to)4230-4237
Number of pages8
JournalBiochemistry
Volume18
Issue number19
DOIs
StatePublished - Jan 1 1979
Externally publishedYes

ASJC Scopus subject areas

  • Biochemistry

Fingerprint Dive into the research topics of 'Pyrrolo[1, 4]benzodiazepine Antibiotics. Biosynthetic Conversion of Tyrosine to the C2- and C3-Proline Moieties of Anthramycin, Tomaymycin, and Sibiromycin'. Together they form a unique fingerprint.

  • Cite this